Sleep & recovery

Narcolepsy: sleepiness, cataplexy, type 1 versus type 2, specialist testing, care, and orexin research

8 sources · Latest source check 2026-10-20 UTC

On this page

Narcolepsy is a disorder of sleep–wake regulation causing excessive daytime sleepiness. Sudden sleep and emotion-triggered muscle weakness are different events. Symptoms can affect study, work, relationships and safety. Nighttime sleep may also be disrupted, so the condition is not simply sleeping too much or failing to get enough rest.[1][2]

Events that can sound similar have different meanings

Events that can sound similar have different meanings
Term	Meaning
Sleep attack	An overwhelming daytime tendency to fall asleep.[2]
Cataplexy	Sudden muscle-tone loss, often emotion-triggered; awareness is retained.[2]
Sleep paralysis	Brief inability to move at sleep onset or awakening.[3]
Sleep-related hallucination	A vivid sensory experience around falling asleep or waking.[3]

Type 1 is associated with orexin deficiency; type 2 lacks cataplexy

Orexin, also called hypocretin, helps regulate wakefulness. Type 1 is associated with loss of orexin-producing neurons and often cataplexy. Type 2 has excessive sleepiness without cataplexy and without the same established deficiency pattern. Classification uses clinical findings and appropriate tests; it is not determined by whether a person remembers one dramatic collapse.[2][7]

Daytime symptoms can coexist with fragmented nighttime sleep

MedlinePlus describes difficult nighttime sleep despite daytime sleepiness. Some people experience several characteristic symptoms and others fewer. Emotion-triggered weakness, dreams around waking and unplanned sleep should be described separately to the clinician rather than combined into one label such as fatigue.[2]

Genetic susceptibility is not a simple single-gene diagnosis

MedlinePlus Genetics describes several susceptibility genes, including HLA-DQB1, and possible immune and environmental contributions. Most cases occur without a known family history, and inheritance is not straightforward. A susceptibility variant differs from a definitive diagnosis or prediction that every relative will develop narcolepsy. This background page is not a complete current gene-discovery review.[3]

The assessment starts with symptoms and sleep context

The NHS describes specialist assessment, a sleep diary, overnight polysomnography and a multiple sleep latency test, with selected spinal-fluid testing. Overnight recording and daytime naps investigate different aspects of sleep. The choice of tests depends on the clinical question, rather than a requirement that everyone undergo every listed procedure.[1]

Preparation can affect what a sleep test means

The 2021 AASM adult protocol guidance covers sleep before testing, medication and substance use, scheduling and documentation. Some changes are consensus-based. A clinician manages preparation, including any medication adjustments. Unsupervised withdrawal to obtain a particular result can be unsafe and can change the condition being measured.[5]

The multiple sleep latency test assesses falling asleep, while the maintenance of wakefulness test addresses staying awake under a testing protocol. They should not be treated as interchangeable, or as guarantees of safety in every real-world task. Adult protocols do not automatically define pediatric testing.[5]

Structured sleep support accompanies medical care

The NHS describes adequate nighttime sleep, regular routines and planned daytime naps, with attention to hazardous activities. It identifies UK DVLA notification requirements and links to current driving rules. Legal requirements vary by jurisdiction; a general article or a better symptom score cannot grant personal driving clearance.[1]

A guideline’s alphabetical list is not a ranking

The 2021 AASM guideline strongly recommends several adult narcolepsy options, including modafinil, pitolisant, sodium oxybate and solriamfetol. It lists recommendations alphabetically within strength groups. Strong versus conditional recommendations differ, and pediatric recommendations are separate. This is dated guidance, not proof that each medicine treats every symptom or is equally suitable for every person.[4]

A medicine used for sleepiness can still depress breathing

The July 2025 Xywav label identifies narcolepsy cataplexy or excessive daytime sleepiness indications, alongside boxed warnings for central nervous system depression and abuse or misuse. It contraindicates combining the product with alcohol or sedative hypnotics. Lower sodium content does not remove oxybate’s neurological or respiratory risks.[6]

Activity can continue while awareness becomes unreliable

Stanford describes automatic behavior when someone fights a sleep attack: a routine activity continues while partly asleep, with little or no later recall—for example, writing words that no longer make sense. Continuing to move or work does not establish reliable alertness. It also describes early childhood cataplexy as sometimes including jaw opening, tongue movements or general weakness before the more familiar emotion-triggered adult pattern develops. Tell the assessment team what happened, rather than requiring every event to resemble a dramatic collapse.[8]

Evidence & uncertainty

Care can improve symptoms, but one subtype’s eight-week experimental trial does not establish a cure for everyone. Diagnostic tests require preparation and clinical interpretation; one sleep score is insufficient.[4][7][5]

Selected-source overview · Independent review pending

Published questions

Are cataplexy and falling asleep the same event?

Selected-source overview · Independent review pending. Read the evidence context.

Cataplexy is loss of muscle tone with retained awareness.[2]

Evidence behind this answer

Narcolepsy: Medical Encyclopedia
agency condition or prevention explanation · 2025
Original indexed clinically reviewed encyclopedia passages inspected · July 2025: types, retained awareness during cataplexy and nighttime disruption